Expression of porcine Mx1 with FMDV IRES enhances the antiviral activity against foot-and-mouth disease virus in PK-15 cells

Archives of Virology

Volumn 160, Issue 8, 2015, Pages 1989-1999

  Yuan, Bing ^a   Fang, Hui ^a   Shen, Chao ^a   Zheng, Congyi ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; ORTHOMYXOVIRIDAE; SUS;

MYXOVIRUS RESISTANCE PROTEIN;

ANIMAL; CELL LINE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; PHYSIOLOGY; PIG; REGULATORY SEQUENCE; VIROLOGY; VIRUS REPLICATION;

ANIMALS; CELL LINE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENE EXPRESSION REGULATION, VIRAL; MYXOVIRUS RESISTANCE PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; SWINE; VIRUS REPLICATION;

EID: 84938965060     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-015-2473-4     Document Type: Article

References (30)

1. Grubman MJ, Baxt B (2004) Foot-and-mouth disease. Clin Microbiol Rev 17:465–493
2. Doel TR (2003) FMD vaccines. Virus Res 91:81–99
3. Moraes MP, de Los Santos T, Koster M, Turecek T, Wang H et al (2007) Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J Virol 81:7124–7135
4. Xiong Y, Lin M, Yuan B, Yuan T, Zheng C (2009) Expression of exogenous IFN-alpha by bypassing the translation block protects cells against FMDV infection. Antivir Res 84:60–66
5. Devaney MA, Vakharia VN, Lloyd RE, Ehrenfeld E, Grubman MJ (1988) Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol 62:4407–4409
6. Kirchweger R, Ziegler E, Lamphear BJ, Waters D, Liebig HD et al (1994) Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J Virol 68:5677–5684
7. de Los Santos T, Diaz-San Segundo F, Grubman MJ (2007) Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J Virol 81:12803–12815
8. Wang D, Fang L, Luo R, Ye R, Fang Y et al (2010) Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels. Biochem Biophys Res Commun 399:72–78
9. Wang D, Fang L, Liu L, Zhong H, Chen Q et al (2011) Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-lambda1 pathway. Mol Immunol 49:407–412
10. Haller O, Gao S, von der Malsburg A, Daumke O, Kochs G (2010) Dynamin-like MxA GTPase: structural insights into oligomerization and implications for antiviral activity. J Biol Chem 285:28419–28424
11. Haller O, Kochs G (2011) Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 31:79–87
12. Palm M, Garigliany MM, Cornet F, Desmecht D (2010) Interferon-induced Sus scrofa Mx1 blocks endocytic traffic of incoming influenza A virus particles. Vet Res 41:29
13. Zhang XM, He DN, Zhou B, Pang R, Liu K et al (2013) In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD). Antivir Res 99:149–157
14. He DN, Zhang XM, Liu K, Pang R, Zhao J et al (2014) In vitro inhibition of the replication of classical swine fever virus by porcine Mx1 protein. Antivir Res 104:128–135
15. Diaz-San Segundo F, Moraes MP, de Los Santos T, Dias CC, Grubman MJ (2010) Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression. J Virol 84:2063–2077
16. Dash P, Barnett PV, Denyer MS, Jackson T, Stirling CM et al (2010) Foot-and-mouth disease virus replicates only transiently in well-differentiated porcine nasal epithelial cells. J Virol 84:9149–9160
17. Rodriguez-Pulido M, Borrego B, Sobrino F, Saiz M (2011) RNA structural domains in noncoding regions of the foot-and-mouth disease virus genome trigger innate immunity in porcine cells and mice. J Virol 85:6492–6501
18. Borrego B, Rodriguez-Pulido M, Mateos F, de la Losa N, Sobrino F et al (2013) Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice. Vaccine 31:4375–4381
19. Zhang X, Shin J, Molitor TW, Schook LB, Rutherford MS (1999) Molecular responses of macrophages to porcine reproductive and respiratory syndrome virus infection. Virology 262:152–162
20. Zhang Q, Gong R, Qu J, Zhou Y, Liu W et al (2012) Activation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathway. J Virol 86:1544–1554
21. Gu C, Zheng C, Shi L, Zhang Q, Li Y et al (2007) Plus- and minus-stranded foot-and-mouth disease virus RNA quantified simultaneously using a novel real-time RT-PCR. Virus Genes 34:289–298
22. Sabara MI, Larence JE (2003) Plaque assay for avian metapneumovirus using a Japanese quail fibrosarcoma cell line (QT-35). J Virol Methods 107:9–14
23. Goodbourn S, Didcock L, Randall RE (2000) Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 81:2341–2364
24. Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P (1998) Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 25:39–47
25. Billiau A (2006) Interferon: the pathways of discovery I. Molecular and cellular aspects. Cytokine Growth Factor Rev 17:381–409
26. Uzri D, Gehrke L (2009) Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J Virol 83:4174–4184
27. Saito T, Owen DM, Jiang F, Marcotrigiano J, Gale M Jr (2008) Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454:523–527
28. Norder H, De Palma AM, Selisko B, Costenaro L, Papageorgiou N et al (2011) Picornavirus non-structural proteins as targets for new anti-virals with broad activity. Antivir Res 89:204–218
29. Haller O, Staeheli P, Kochs G (2007) Interferon-induced Mx proteins in antiviral host defense. Biochimie 89:812–818
30. Cilloniz C, Pantin-Jackwood MJ, Ni C, Carter VS, Korth MJ et al (2012) Molecular signatures associated with Mx1-mediated resistance to highly pathogenic influenza virus infection: mechanisms of survival. J Virol 86:2437–2446